Kamel Mamchaoui

5.0k total citations
94 papers, 3.3k citations indexed

About

Kamel Mamchaoui is a scholar working on Molecular Biology, Cell Biology and Physiology. According to data from OpenAlex, Kamel Mamchaoui has authored 94 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Molecular Biology, 15 papers in Cell Biology and 15 papers in Physiology. Recurrent topics in Kamel Mamchaoui's work include Muscle Physiology and Disorders (41 papers), RNA Research and Splicing (20 papers) and CRISPR and Genetic Engineering (14 papers). Kamel Mamchaoui is often cited by papers focused on Muscle Physiology and Disorders (41 papers), RNA Research and Splicing (20 papers) and CRISPR and Genetic Engineering (14 papers). Kamel Mamchaoui collaborates with scholars based in France, United Kingdom and Italy. Kamel Mamchaoui's co-authors include Vincent Mouly, Gillian Butler‐Browne, Anne Bigot, R.N. Cooper, Denis Furling, James P. Di Santo, Gisèle Bonne, Georges Saumon, Jerry W. Shay and Woodring E. Wright and has published in prestigious journals such as Nature, Science and Nucleic Acids Research.

In The Last Decade

Kamel Mamchaoui

90 papers receiving 3.3k citations

Peers

Countries citing papers authored by Kamel Mamchaoui

Since Specialization

Citations

This map shows the geographic impact of Kamel Mamchaoui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kamel Mamchaoui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kamel Mamchaoui more than expected).

Fields of papers citing papers by Kamel Mamchaoui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kamel Mamchaoui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kamel Mamchaoui. The network helps show where Kamel Mamchaoui may publish in the future.

Co-authorship network of co-authors of Kamel Mamchaoui

This figure shows the co-authorship network connecting the top 25 collaborators of Kamel Mamchaoui. A scholar is included among the top collaborators of Kamel Mamchaoui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kamel Mamchaoui. Kamel Mamchaoui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characterization of DMPK and MBNL1 expression in cell models of myotonic dystrophy: a platform for drug screening 2025 ·PubMed ·(unknown), (unknown), (unknown), (unknown), (unknown), Adolfo López de Munain, Anne Bigot, Kamel Mamchaoui, Gisela Nogales‐Gadea, Virginia Arechavala‐Gomeza	0
2	Functional benefit of CRISPR-Cas9-induced allele deletion for RYR1 dominant mutation 2024 ·Molecular Therapy — Nucleic Acids ·(unknown), (unknown), Julie Brocard, (unknown), (unknown), Kamel Mamchaoui, Norma B. Romero, (unknown), Susana Quijano‐Roy, Julien Fauré, John Rendu, Isabelle Marty	1
3	Correction of exon 2, exon 2–9 and exons 8–9 duplications in DMD patient myogenic cells by a single CRISPR/Cas9 system 2024 ·Scientific Reports ·(unknown), (unknown), (unknown), (unknown), (unknown), Kamel Mamchaoui, (unknown), Guillaume Corre, Matteo Bovolenta, Isabelle Richard	1
4	Immortalized human myotonic dystrophy type 1 muscle cell lines to address patient heterogeneity 2024 ·iScience ·(unknown), (unknown), Alicia Martínez‐Piñeiro, (unknown), Jovan Pešović, (unknown), (unknown), (unknown), (unknown), Estefanía Cerro-Herreros, (unknown), Adolfo López de Munaín, Rubén Artero, Dušanka Savić‐Pavićević, Ainara Vallejo‐Illarramendi, Kamel Mamchaoui, Anne Bigot, Vincent Mouly, Mònica Suelves, Gisela Nogales‐Gadea	4
5	Cellular and Genomic Features of Muscle Differentiation from Isogenic Fibroblasts and Myoblasts 2023 ·Cells ·Louise Benarroch, (unknown), (unknown), Kamel Mamchaoui, (unknown), Anne Bigot, Vincent Mouly, Gisèle Bonne, A. Bertrand, Philippe Collas	3
6	Inactivation of Sirt6 ameliorates muscular dystrophy in mdx mice by releasing suppression of utrophin expression 2022 ·Nature Communications ·(unknown), (unknown), Marek Bartkuhn, Stefan Günther, Carsten Künne, Christian Smolka, Ann Atzberger, (unknown), Kamel Mamchaoui, Eva Bober, Yonggang Zhou, Xuejun Yuan, Thomas Braun	12
7	Moxifloxacin rescues SMA phenotypes in patient-derived cells and animal model 2022 ·Cellular and Molecular Life Sciences ·(unknown), (unknown), Kamel Mamchaoui, Cécile Martinat, Rubén Artero, (unknown), Marina Boido	9
8	Interplay between mitochondrial reactive oxygen species, oxidative stress and hypoxic adaptation in facioscapulohumeral muscular dystrophy: Metabolic stress as potential therapeutic target 2022 ·Redox Biology ·Philipp Heher, Massimo Ganassi, Adelheid Weidinger, Elise N. Engquist, Johanna Prüller, (unknown), Alexandra Tassin, Anne‐Émilie Declèves, Kamel Mamchaoui, Christopher R. S. Banerji, Johannes Grillari, Andrey V. Kozlov, Peter S. Zammit	44
9	Synthesis and Exon-Skipping Properties of a 3′-Ursodeoxycholic Acid-Conjugated Oligonucleotide Targeting DMD Pre-mRNA: Pre-Synthetic versus Post-Synthetic Approach 2021 ·Molecules ·Elena Marchesi, Matteo Bovolenta, (unknown), Massimo L. Capobianco, Kamel Mamchaoui, Monica Bertoldo, Daniela Perrone	3
10	Adenylosuccinic acid therapy ameliorates murine Duchenne Muscular Dystrophy 2020 ·Scientific Reports ·Cara A. Timpani, Craig A. Goodman, Christos G. Stathis, Jason D. White, Kamel Mamchaoui, Gillian Butler‐Browne, Nuri Gueven, Alan Hayes, Emma Rybalka	27
11	Alternative splicing of clathrin heavy chain contributes to the switch from coated pits to plaques 2020 ·The Journal of Cell Biology ·Gilles Moulay, Jeanne Lainé, (unknown), Masayuki Nakamori, Ichizo Nishino, Ghislaine Caillol, Kamel Mamchaoui, Laura Julien, Florent Dingli, Damarys Loew, Marc Bitoun, Christophe Leterrier, Denis Furling, Stéphane Vassilopoulos	34
12	Lamin-Related Congenital Muscular Dystrophy Alters Mechanical Signaling and Skeletal Muscle Growth 2020 ·International Journal of Molecular Sciences ·Daniel J. Owens, (unknown), Sophie Moog, (unknown), Arnaud Ferry, Kamel Mamchaoui, Emmanuelle Lacène, Norma B. Romero, Astrid Brull, Gisèle Bonne, Gillian Butler‐Browne, Catherine Coirault	21
13	<p>Simplified in vitro engineering of neuromuscular junctions between rat embryonic motoneurons and immortalized human skeletal muscle cells</p> 2019 ·SHILAP Revista de lepidopterología ·(unknown), Alessandro Faroni, (unknown), Adam J. Reid, Adam P. Lightfoot, Kamel Mamchaoui, Vincent Mouly, Gillian Butler‐Browne, Jamie S. McPhee, Hans Degens, Nasser Al‐Shanti	9
14	A functional human motor unit platform engineered from human embryonic stem cells and immortalized skeletal myoblasts 2018 ·SHILAP Revista de lepidopterología ·(unknown), Jamie S. McPhee, (unknown), Tristan R. McKay, Lorna M. FitzPatrick, Kamel Mamchaoui, Anne Bigot, Vincent Mouly, Gillian Butler‐Browne, Nasser Al‐Shanti	7
15	Lamins and nesprin-1 mediate inside-out mechanical coupling in muscle cell precursors through FHOD1 2017 ·Scientific Reports ·Christine Schwartz, Martina Fischer, Kamel Mamchaoui, Anne Bigot, (unknown), Claude Verdier, Alain Duperray, R. Michel, Ian Holt, Thomas Voit, (unknown), Gisèle Bonne, Catherine Coirault	38
16	Short (16-mer) locked nucleic acid splice-switching oligonucleotides restore dystrophin production in Duchenne Muscular Dystrophy myotubes 2017 ·PLoS ONE ·(unknown), (unknown), Kamel Mamchaoui, Célia Carvalho, Maria Carmo‐Fonseca	7
17	ZNF555 protein binds to transcriptional activator site of 4qA allele andANT1: potential implication in Facioscapulohumeral dystrophy 2015 ·Nucleic Acids Research ·(unknown), Jeremy N. Rich, Adam Karoutas, Pavel Tarlykov, (unknown), (unknown), Kamel Mamchaoui, Vasily Ogryzko, Iryna Pirozhkova	12
18	FUBP1: a new protagonist in splicing regulation of the DMD gene 2015 ·Nucleic Acids Research ·Julie Miro, (unknown), Valérie Rofidal, (unknown), Sonia Hem, (unknown), (unknown), Kamel Mamchaoui, Vincent Mouly, Mireille Claustres, Sylvie Tuffery‐Giraud	28
19	Generation of Isogenic D4Z4 Contracted and Noncontracted Immortal Muscle Cell Clones from a Mosaic Patient 2012 ·American Journal Of Pathology ·Yvonne D. Krom, Julie Dumonceaux, Kamel Mamchaoui, Bianca den Hamer, Virginie Mariot, Elisa Négroni, Linda N. Geng, Nicolas Martin, Rabi Tawil, Stephen J. Tapscott, Baziel G.M. van Engelen, Vincent Mouly, Gillian Butler‐Browne, Silvère M. van der Maarel	66
20	Human circulating AC133+ stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle 2004 ·Journal of Clinical Investigation ·Yvan Torrente, M. Belicchi, Maurilio Sampaolesi, Federica Pisati, Mirella Meregalli, Giuseppe D’Antona, Rossana Tonlorenzi, Laura Porretti, Manuela Gavina, Kamel Mamchaoui, Maria Antonietta Pellegrino, Denis Furling, Vincent Mouly, Gillian Butler‐Browne, Roberto Bottinelli, Giulio Cossu, Nereo Bresolin	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact